IT1405758B1 - Preparazione farmaceutica a base nac in soluzione ipertonica per il trattamento di affezioni rinofaringee - Google Patents
Preparazione farmaceutica a base nac in soluzione ipertonica per il trattamento di affezioni rinofaringeeInfo
- Publication number
- IT1405758B1 IT1405758B1 ITNA2010A000054A ITNA20100054A IT1405758B1 IT 1405758 B1 IT1405758 B1 IT 1405758B1 IT NA2010A000054 A ITNA2010A000054 A IT NA2010A000054A IT NA20100054 A ITNA20100054 A IT NA20100054A IT 1405758 B1 IT1405758 B1 IT 1405758B1
- Authority
- IT
- Italy
- Prior art keywords
- rinofaringeal
- affections
- treatment
- pharmaceutical preparation
- hypertonic solution
- Prior art date
Links
- 239000000819 hypertonic solution Substances 0.000 title 1
- 229940021223 hypertonic solution Drugs 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Otolaryngology (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITNA2010A000054A IT1405758B1 (it) | 2010-11-03 | 2010-11-03 | Preparazione farmaceutica a base nac in soluzione ipertonica per il trattamento di affezioni rinofaringee |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITNA2010A000054A IT1405758B1 (it) | 2010-11-03 | 2010-11-03 | Preparazione farmaceutica a base nac in soluzione ipertonica per il trattamento di affezioni rinofaringee |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ITNA20100054A1 ITNA20100054A1 (it) | 2012-05-04 |
| IT1405758B1 true IT1405758B1 (it) | 2014-01-24 |
Family
ID=43742878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITNA2010A000054A IT1405758B1 (it) | 2010-11-03 | 2010-11-03 | Preparazione farmaceutica a base nac in soluzione ipertonica per il trattamento di affezioni rinofaringee |
Country Status (1)
| Country | Link |
|---|---|
| IT (1) | IT1405758B1 (it) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE901885A (fr) * | 1985-03-06 | 1985-07-01 | Bruschettini Srl | Composition pharmaceutique sous forme de lotion ophtalmique et son procede de preparation. |
| EP1007077B1 (en) * | 1997-01-13 | 2009-10-07 | Emory University | Glutathione for the treatment of influenza infection |
| IT1313567B1 (it) * | 1999-07-27 | 2002-09-09 | Zambon Spa | Uso della n-acetil-cisteina per la preparazione di composizionifarmaceutiche topiche per il trattamento di patologie allergiche delle |
| EP1609468A3 (en) * | 2000-11-22 | 2006-01-25 | Rxkinetix, Inc. | A composition on the basis of a sulfur-containing antioxidant and its use for the manufacture of a medicament for treating mucositis |
-
2010
- 2010-11-03 IT ITNA2010A000054A patent/IT1405758B1/it active
Also Published As
| Publication number | Publication date |
|---|---|
| ITNA20100054A1 (it) | 2012-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201600285B (it) | Procedimento per la fabbricazione di una preparazione farmaceutica contenente ipp | |
| CO6852076A2 (es) | Composiciones farmacéuticas inhalables | |
| DK2641614T3 (da) | Farmaceutisk præparat integreret med mikronåle til hudbehandling | |
| SMT201500126B (it) | Nuova composizione farmaceutica resistente all'abuso per il trattamento di una dipendenza da oppioidi | |
| SMT201400069B (it) | Formulazione farmaceutica | |
| GT201200303A (es) | Formulaciones farmacéuticas | |
| ITTO20110641A1 (it) | Composizioni farmaceutiche e metodi di trattamento | |
| DK2652652T3 (da) | Medikmentadministration | |
| BR112012026686A2 (pt) | fórmulas melhoradas para dispositivos médicos revestidos com droga | |
| BR112013012476A2 (pt) | formulações farmacêuticas contendo corticosteróides para administração tópica | |
| BRPI1005433A2 (pt) | preparações farmacêuticas transdérmicas | |
| CO6940426A2 (es) | Formulaciones farmacéuticas | |
| CO6950486A2 (es) | Solución para administración oral | |
| BR112013022556A2 (pt) | composição farmacêutica aquosa semissólida contendo tapentadol | |
| SMT201500005B (it) | Composizione framaceutica inalabile | |
| CU24163B1 (es) | Composición farmacéutica oftalmológica tópica que contiene regorafenib | |
| EE201300004A (et) | Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks | |
| BR112014015885A2 (pt) | preparação farmacêutica | |
| DE102009018133A8 (de) | Pharmazeutische Zusammensetzung zur Behandlung von dermatologischen Autoimmunerkrankungen | |
| ZA201306239B (en) | Storage-stable formulation of paracetamol in aqueous solution | |
| FR2958166B1 (fr) | Compositions pharmaceutiques fortement dosees en biotine | |
| IL227651A (en) | Topical pharmacological formulations containing 220b | |
| BR112013030930A2 (pt) | composições farmacêuticas combinadas para o tratamento de tumores | |
| DK2714042T3 (da) | En analgetisk farmaceutisk sammensætning til oral administration | |
| IL238071B (en) | Pharmaceutical composition of 1-adamantylethyloxy-3-morpholino-2-propanol or pharmaceutically acceptable salts thereof for the treatment of cardiovascular disease |